Posters Presentation
Stay tuned for more information regarding our joint posters, covering multi-center real-world studies in growing the understanding of immune checkpoint inhibitors (ICIs) treatment in real-world cancer patients.

Unlock Insights in Immuno-Oncology
The comprehensive immuno-oncology datasets within LynxCare's European hospital network offer deep clinical insights into patients treated with Immune Checkpoint Inhibitors. By leveraging LynxCare's clinical NLP+AI technology,  up to 80% of clinical outcomes siloed and locked in clinical reports become accessible. This allows fresh perspectives on a.o. comorbidity factors, treatment patterns, adverse events (cardiotoxicity) and median overall survival.